200 related articles for article (PubMed ID: 15950902)
1. CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness.
Michl P; Ramjaun AR; Pardo OE; Warne PH; Wagner M; Poulsom R; D'Arrigo C; Ryder K; Menke A; Gress T; Downward J
Cancer Cell; 2005 Jun; 7(6):521-32. PubMed ID: 15950902
[TBL] [Abstract][Full Text] [Related]
2. WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.
Ripka S; König A; Buchholz M; Wagner M; Sipos B; Klöppel G; Downward J; Gress T; Michl P
Carcinogenesis; 2007 Jun; 28(6):1178-87. PubMed ID: 17227781
[TBL] [Abstract][Full Text] [Related]
3. CUTL1 is phosphorylated by protein kinase A, modulating its effects on cell proliferation and motility.
Michl P; Knobel B; Downward J
J Biol Chem; 2006 Jun; 281(22):15138-44. PubMed ID: 16574653
[TBL] [Abstract][Full Text] [Related]
4. CUTL1: a key mediator of TGFbeta-induced tumor invasion.
Michl P; Downward J
Cell Cycle; 2006 Jan; 5(2):132-4. PubMed ID: 16357536
[TBL] [Abstract][Full Text] [Related]
5. CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation.
Aleksic T; Bechtel M; Krndija D; von Wichert G; Knobel B; Giehl K; Gress TM; Michl P
Oncogene; 2007 Aug; 26(40):5939-49. PubMed ID: 17369846
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional repressor CDP (Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle.
Ellis T; Gambardella L; Horcher M; Tschanz S; Capol J; Bertram P; Jochum W; Barrandon Y; Busslinger M
Genes Dev; 2001 Sep; 15(17):2307-19. PubMed ID: 11544187
[TBL] [Abstract][Full Text] [Related]
7. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
[TBL] [Abstract][Full Text] [Related]
8. CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer.
Wang J; Wang Y; Sun D; Ren F; Pang S; Xu S
Oncol Rep; 2017 May; 37(5):3068-3074. PubMed ID: 28405678
[TBL] [Abstract][Full Text] [Related]
9. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.
Singh K; Mogare D; Giridharagopalan RO; Gogiraju R; Pande G; Chattopadhyay S
PLoS One; 2007 Aug; 2(7):e660. PubMed ID: 17668048
[TBL] [Abstract][Full Text] [Related]
10. Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.
Ripka S; Riedel J; Neesse A; Griesmann H; Buchholz M; Ellenrieder V; Moeller F; Barth P; Gress TM; Michl P
Neoplasia; 2010 Aug; 12(8):659-67. PubMed ID: 20689760
[TBL] [Abstract][Full Text] [Related]
11. Cutl1: a potential target for cancer therapy.
Liu KC; Lin BS; Zhao M; Wang KY; Lan XP
Cell Signal; 2013 Jan; 25(1):349-54. PubMed ID: 23085261
[TBL] [Abstract][Full Text] [Related]
12. HOXD3 enhances motility and invasiveness through the TGF-beta-dependent and -independent pathways in A549 cells.
Miyazaki YJ; Hamada J; Tada M; Furuuchi K; Takahashi Y; Kondo S; Katoh H; Moriuchi T
Oncogene; 2002 Jan; 21(5):798-808. PubMed ID: 11850808
[TBL] [Abstract][Full Text] [Related]
13. Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.
Fullerton PT; Creighton CJ; Matzuk MM
Mol Endocrinol; 2015 Oct; 29(10):1440-53. PubMed ID: 26284758
[TBL] [Abstract][Full Text] [Related]
14. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
15. MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer.
Nguyen HL; Kadam P; Helkin A; Cao K; Wu S; Samara GJ; Zhang Q; Zucker S; Cao J
Curr Cancer Drug Targets; 2016; 16(7):618-30. PubMed ID: 26881932
[TBL] [Abstract][Full Text] [Related]
16. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA.
Jayaraman S; Doucet M; Kominsky SL
Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor CUTL1 is associated with proliferation and prognosis in malignant melanoma.
Fan X; Wang H; Zhou J; Wang S; Zhang X; Li T; Nie Y; Liu B
Melanoma Res; 2014 Jun; 24(3):198-206. PubMed ID: 24686420
[TBL] [Abstract][Full Text] [Related]
19. KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells.
Ellenrieder V; Buck A; Harth A; Jungert K; Buchholz M; Adler G; Urrutia R; Gress TM
Gastroenterology; 2004 Aug; 127(2):607-20. PubMed ID: 15300592
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
